Janssen RS, Valdiserri RO: HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr 2004, 37(Suppl 2):S119-121.Janssen RS, Valdiserri RO: HIV prevention in the United States: increasing emphasis on working with those ...
In the United States, 1.1 million people live with human immunodeficiency virus (HIV), a 60% increase from 15 years ago. The increasing number of people who can potentially transmit HIV makes prevention more difficult. Yet federal domestic HIV prevention funding, after adjustment for inflation, ...
18 In this context, innovations in long-acting ART have the potential to be extended from treatment to prevention. Continuing Innovation in Treatment and Prevention Access Today’s access challenges will require continued evaluation and innovation. Diligent and responsive programs that regularly refine ...
HIV prevention scienceracial disparityThe article presents a study of the human immunodeficiency virus (HIV) prevention among women in the U.S. The study summarizes the epidemiology of HIV and acquired immune deficiency syndrome (AIDS) among women in the country. It also discusses the public ...
OBJECTIVES: To compare the prevalence of high-risk sexual behaviors in HIV persons aware of their serostatus with that in HIV persons unaware of their status in the United States and to discuss implications for HIV prevention programs. METHODS: A meta-analysis was conducted on 11 independent find...
Centers for Disease Control and Prevention (CDC). US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update: Clinical Providers’ Supplement. CDC website. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-provider-supplement-2017.pd...
For more information on PrEP and the other high risk factors associated with HIV, the CDC has put together a PrEP 101 Fact Sheet. Prevention and adherence to drug therapy can play a critical role in managing this epidemic. Today in the United States, 2 drugs are approved for PrEP therapy:...
Objective Based on a critical evaluation of new data, to provide clinicians with recommendations on use of antiretroviral drugs for the treatment and prevention of HIV, laboratory monitoring, care of people aging with HIV, substance use disorder and HIV, and new challenges in people with HIV, inc...
Racial/ethnic inequities along the HIV care continuum persist in the United States despite substantial federal investment. Numerous studies highlight individual and social-level impediments in HIV, but fewer foreground systemic barriers. The present qual
Mayers KH., et al, EvolvingModels and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation inthe United States. J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127.Credit: moodboard via Thinkstock Although the Centers for Disease Control and Prevention (CDC) estimates that just ...